Abstract
CHAMPAIN study: Initial results from a phase II study of efficacy, safety and tolerability of modified-release hydrocortisones: Chronocort® (Efmody®) versus Plenadren®, in primary adrenal insufficiency
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have